HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giovanni Cammarota Selected Research

Metabolic Syndrome (Dysmetabolic Syndrome X)

12/2012Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giovanni Cammarota Research Topics

Disease

35Clostridium Infections
05/2024 - 01/2014
15Infections
04/2024 - 12/2002
15Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
05/2023 - 10/2014
9Neoplasms (Cancer)
05/2024 - 06/2009
9Inflammation (Inflammations)
07/2023 - 09/2006
9Celiac Disease (Celiac Sprue)
03/2019 - 03/2003
8Ulcerative Colitis
10/2023 - 01/2007
8Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
07/2023 - 04/2006
6Diarrhea
07/2021 - 01/2005
5Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
07/2023 - 01/2016
5Dysbiosis
05/2023 - 06/2014
4Lactose Intolerance (Intolerance, Lactose)
01/2016 - 01/2006
3Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2024 - 01/2019
3COVID-19
07/2023 - 01/2020
3Pseudomembranous Enterocolitis (Pseudomembranous Colitis)
02/2022 - 09/2014
3Colitis
01/2022 - 12/2013
3Liver Diseases (Liver Disease)
06/2021 - 01/2016
3Diverticular Diseases
10/2016 - 09/2003
2Renal Cell Carcinoma (Grawitz Tumor)
12/2023 - 01/2020
2Crohn Disease (Crohn's Disease)
11/2022 - 07/2008
2Melanoma (Melanoma, Malignant)
01/2022 - 01/2017
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2021 - 04/2004
2Intestinal Diseases (Diseases, Intestinal)
01/2019 - 08/2007
2Non-alcoholic Fatty Liver Disease
01/2018 - 06/2009
2Necrosis
01/2017 - 04/2016
2Colonic Neoplasms (Colon Cancer)
11/2016 - 06/2004
2Dyspepsia (Indigestion)
11/2016 - 04/2004
2Pain (Aches)
01/2015 - 09/2003
2Gastritis
07/2010 - 09/2003
1Erythema elevatum diutinum
07/2023
1Leukocytosis (Pleocytosis)
07/2023
1IgA Vasculitis (Purpura, Schoenlein Henoch)
07/2023
1Vasculitis (Vasculitides)
07/2023
1Colorectal Neoplasms (Colorectal Cancer)
05/2023
1Intestinal Failure
11/2022
1Short Bowel Syndrome
11/2022
1Noncommunicable Diseases
01/2022
1Communicable Diseases (Infectious Diseases)
01/2022
1Vomiting
11/2021
1Abdominal Pain (Pain, Abdominal)
11/2021
1Malnutrition (Nutritional Deficiencies)
11/2021
1Fibrosis (Cirrhosis)
01/2021
1Mental Disorders (Mental Disorder)
01/2021
1Bacterial Infections (Bacterial Infection)
01/2021
1Rheumatoid Arthritis
01/2020
1Chronic Disease (Chronic Diseases)
01/2020
1Sepsis (Septicemia)
11/2019
1Lung Neoplasms (Lung Cancer)
01/2019
1Insulin Resistance
01/2018
1Diverticulitis
10/2016
1Colonic Diverticulitis
10/2016

Drug/Important Bio-Agent (IBA)

12Anti-Bacterial Agents (Antibiotics)IBA
02/2022 - 04/2006
6Leukocyte L1 Antigen Complex (Calgranulin)IBA
11/2020 - 01/2007
5Proton Pump InhibitorsIBA
01/2021 - 04/2004
5Infliximab (Remicade)FDA Link
01/2017 - 11/2012
4AntibodiesIBA
01/2017 - 03/2003
4LactaseIBA
01/2016 - 01/2005
3C-Reactive ProteinIBA
10/2016 - 06/2004
3Bile Acids and Salts (Bile Acids)IBA
01/2016 - 06/2007
2SuspensionsIBA
04/2024 - 09/2014
2Immunoglobulin A (IgA)IBA
07/2023 - 01/2005
2Volatile Fatty AcidsIBA
05/2023 - 05/2023
2CarbohydratesIBA
06/2021 - 01/2016
2EnzymesIBA
06/2021 - 01/2016
2Glutens (Glutelin)IBA
03/2019 - 06/2012
2Immunosuppressive Agents (Immunosuppressants)IBA
01/2017 - 11/2012
2Rifaximin (L 105)FDA Link
07/2016 - 01/2016
2Proteins (Proteins, Gene)FDA Link
01/2016 - 08/2007
2PrebioticsIBA
05/2015 - 06/2014
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2012 - 07/2008
2LactoseFDA LinkGeneric
06/2008 - 01/2005
1fibrin fragment D (D-dimer)IBA
07/2023
1VaccinesIBA
07/2023
1Histamine (Histamine Dihydrochloride)FDA Link
07/2023
1Glucagon (Glukagon)FDA Link
11/2022
1NexusIBA
06/2022
1Peptide Hydrolases (Proteases)FDA Link
11/2021
1Angiotensin Receptors (Angiotensin II Receptor)IBA
11/2021
1Serotonin (5 Hydroxytryptamine)IBA
06/2021
1Bacterial ToxinsIBA
06/2021
1Tyrosine Kinase InhibitorsIBA
01/2020
1Viral RNAIBA
01/2020
1Bacteriocins (Lantibiotics)IBA
01/2019
1Metformin (Glucophage)FDA LinkGeneric
01/2019
1Insulin (Novolin)FDA Link
01/2018
1Ethanol (Ethyl Alcohol)IBA
01/2018
1IpilimumabIBA
01/2017
1Mesalamine (Mesalazine)FDA LinkGeneric
01/2017
1Biomarkers (Surrogate Marker)IBA
10/2016
117-hydroxyestrane-3-carbonitrile (ECN)IBA
06/2016
1Cadherins (E-Cadherin)IBA
04/2016

Therapy/Procedure

35Fecal Microbiota Transplantation
05/2024 - 09/2014
22Therapeutics
12/2023 - 07/2003
15Transplantation
04/2023 - 05/2014
5Immunotherapy
05/2024 - 10/2013
5Gluten-Free Diet
11/2021 - 11/2007
2Enema (Enemas)
09/2014 - 12/2013
1Precision Medicine
10/2020
1Length of Stay
11/2019
1Complementary Therapies (Alternative Medicine)
06/2016